Clinical Features, Diagnosis and Treatment Outcome of Fungal Endocarditis: A Systematic Review of Reported Cases

Mycoses ◽  
2021 ◽  
Author(s):  
Durga Shankar Meena ◽  
Deepak Kumar ◽  
Madhulata Agarwal ◽  
Gopal Krishana Bohra ◽  
Rahul Choudhary ◽  
...  
Keyword(s):  
Systematic Review ◽  
Treatment Outcome ◽  
Clinical Features ◽  
Diagnosis And Treatment ◽  
Fungal Endocarditis

Epidemiology, clinical features, diagnosis and treatment of cerebral mucormycosis in diabetic patients: A systematic review of case reports and case series

Mycoses ◽  
2020 ◽  
Vol 63 (12) ◽  
pp. 1264-1282
Author(s):  
Zahra Chegini ◽  
Mojtaba Didehdar ◽  
Amin Khoshbayan ◽  
Shahin Rajaeih ◽  
Mohammadreza Salehi ◽  
...  
Keyword(s):  
Systematic Review ◽  
Clinical Features ◽  
Case Reports ◽  
Case Series ◽  
Diagnosis And Treatment ◽  
Diabetic Patients

scholarly journals Biliary Atresia: A Systematic Review of Etiology, Pathogenesis, Diagnosis and Treatment

2020 ◽  
Vol I (3) ◽  
pp. 43-49
Author(s):  
Julio César Moreno Alfonso
Keyword(s):  
Systematic Review ◽  
Liver Transplantation ◽  
Biliary Atresia ◽  
Clinical Features ◽  
Bile Flow ◽  
Neonatal Jaundice ◽  
Diagnosis And Treatment ◽  
Preventive Strategies ◽  
Review Of The Literature ◽  
Common Indication

Biliary Atresia (BA) is an uncommon, progressive and idiopathic fibro-obliterative cholangiopathy. The typical clinical features should be identified prompt in order to realize a Kasai Hepatoportoenterostomy (HPE) for restore the bile flow. However, despite HPE the BA remains the most common indication for liver transplantation in children. The lasts studies have shown the importance of virus, immunity and other environmental substances in pathogenesis of BA that is important in order to look for new therapeutic and preventive strategies. This article is a systematic review of the literature about actual evidence in BA. Keywords: Biliary atresia; Neonatal jaundice; Kasai hepatoportoenterostomy; Liver transplantation

scholarly journals Clinical features, molecular diagnosis, and treatment outcome of infants with leukemia in Taiwan

2010 ◽  
Vol 55 (7) ◽  
pp. 1264-1271 ◽  
Author(s):  
Shih-Hsiang Chen ◽  
Chao-Ping Yang ◽  
Iou-Jih Hung ◽  
Tang-Her Jaing ◽  
Lee-Yung Shih ◽  
...  
Keyword(s):  
Treatment Outcome ◽  
Clinical Features ◽  
Molecular Diagnosis ◽  
Diagnosis And Treatment

Facet syndrome: causes, clinical features, diagnosis and treatment

2016 ◽  
Vol 18 (2) ◽  
pp. 53-61 ◽  
Author(s):  
A.I. Isaykin ◽  
◽  
I.V. Kuznetsov ◽  
A.V. Kavelina ◽  
M.A. Ivanova ◽  
...  
Keyword(s):  
Clinical Features ◽  
Diagnosis And Treatment ◽  
Facet Syndrome

scholarly journals Clinical features and outcomes of pregnant women with COVID-19: a systematic review and meta-analysis

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Yi-jie Gao ◽  
Lei Ye ◽  
Jia-shuo Zhang ◽  
Yang-xue Yin ◽  
Min Liu ◽  
...  
Keyword(s):  
Systematic Review ◽  
Pregnant Women ◽  
Clinical Features ◽  
Meta Analysis

scholarly journals Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Sunny Singhal ◽  
Pramod Kumar ◽  
Sumitabh Singh ◽  
Srishti Saha ◽  
Aparajit Ballav Dey
Keyword(s):  
Systematic Review ◽  
Older Adults ◽  
Critically Ill ◽  
Clinical Features ◽  
Older Patients ◽  
Clinical Characteristics ◽  
Meta Analysis ◽  
Severe Infection ◽  
Factors Affecting ◽  
Pooled Prevalence

Abstract Background Few studies have focused on exploring the clinical characteristics and outcomes of COVID-19 in older patients. We conducted this systematic review and meta-analysis to have a better understanding of the clinical characteristics of older COVID-19 patients. Methods A systematic search of PubMed and Scopus was performed from December 2019 to May 3rd, 2020. Observational studies including older adults (age ≥ 60 years) with COVID-19 infection and reporting clinical characteristics or outcome were included. Primary outcome was assessing weighted pooled prevalence (WPP) of severity and outcomes. Secondary outcomes were clinical features including comorbidities and need of respiratory support. Result Forty-six studies with 13,624 older patients were included. Severe infection was seen in 51% (95% CI– 36-65%, I2–95%) patients while 22% (95% CI– 16-28%, I2–88%) were critically ill. Overall, 11% (95% CI– 5-21%, I2–98%) patients died. The common comorbidities were hypertension (48, 95% CI– 36-60% I2–92%), diabetes mellitus (22, 95% CI– 13-32%, I2–86%) and cardiovascular disease (19, 95% CI – 11-28%, I2–85%). Common symptoms were fever (83, 95% CI– 66-97%, I2–91%), cough (60, 95% CI– 50-70%, I2–71%) and dyspnoea (42, 95% CI– 19-67%, I2–94%). Overall, 84% (95% CI– 60-100%, I2–81%) required oxygen support and 21% (95% CI– 0-49%, I2–91%) required mechanical ventilation. Majority of studies had medium to high risk of bias and overall quality of evidence was low for all outcomes. Conclusion Approximately half of older patients with COVID-19 have severe infection, one in five are critically ill and one in ten die. More high-quality evidence is needed to study outcomes in this vulnerable patient population and factors affecting these outcomes.

Sign in / Sign up

Export Citation Format

Share Document